ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling

J Cell Biol. 2022 Jul 4;221(7):e202106046. doi: 10.1083/jcb.202106046. Epub 2022 Jun 3.

Abstract

Mutations in VPS13C cause early-onset, autosomal recessive Parkinson's disease (PD). We have established that VPS13C encodes a lipid transfer protein localized to contact sites between the ER and late endosomes/lysosomes. In the current study, we demonstrate that depleting VPS13C in HeLa cells causes an accumulation of lysosomes with an altered lipid profile, including an accumulation of di-22:6-BMP, a biomarker of the PD-associated leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. In addition, the DNA-sensing cGAS-STING pathway, which was recently implicated in PD pathogenesis, is activated in these cells. This activation results from a combination of elevated mitochondrial DNA in the cytosol and a defect in the degradation of activated STING, a lysosome-dependent process. These results suggest a link between ER-lysosome lipid transfer and innate immune activation in a model human cell line and place VPS13C in pathways relevant to PD pathogenesis.

MeSH terms

  • DNA, Mitochondrial* / genetics
  • Endoplasmic Reticulum* / metabolism
  • HeLa Cells
  • Humans
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / metabolism
  • Lipids
  • Lysosomes / metabolism
  • Membrane Proteins* / metabolism
  • Mutation
  • Parkinson Disease* / metabolism
  • Proteins* / metabolism

Substances

  • DNA, Mitochondrial
  • Lipids
  • Membrane Proteins
  • Proteins
  • STING1 protein, human
  • VPS13C protein, human
  • LRRK2 protein, human
  • Leucine-Rich Repeat Serine-Threonine Protein Kinase-2